E. Chester Ridgway, MD, to Receive the American Thyroid Association’s Inaugural Lewis E. Braverman Lectureship Award

Falls Church, Virginia. Oct. 27, 2011 – The American Thyroid Association’s (ATA) Lewis E. Braverman Lectureship Award recognizes a member of the ATA who has demonstrated excellence and passion for mentoring fellows, students, and junior faculty and has a long history of productive thyroid research. E. Chester “Chip” Ridgway, MD, the first awardee of this newly endowed Lewis E. Braverman Lectureship Award, will deliver his lecture on October 29, 2011, at its 81st Annual Meeting, held October 26-30 in Indian Wells, California.

Dr. Ridgway holds several key positions at the University of Colorado School of Medicine, including Executive Vice Chair Medicine, Frederic Hamilton Professor of Medicine and Senior Associate Dean for Academic Affairs. He came to the University of Colorado in 1985 to become Head of the Division of Endocrinology, Metabolism, and Diabetes, and he served in that capacity until 2007. Previously, he was Head of the Thyroid Unit at Massachusetts General Hospital, in Boston.

His research centers on thyroid stimulating hormone and its regulation of the thyroid gland, focusing specifically on the development and regulatory factors that control the alpha and beta subunits of thyroid stimulating hormone. He has also extensively studied the role of thyroid hormones in altered cardiac, brain, pulmonary, skeletal muscle, hepatic, and adipocyte function associated with disorders of the thyroid gland and the identification of therapeutic strategies.

Dr. Ridgway is a past-president of the ATA (1996-1997) and of the Endocrine Society (2003-2004). He has served in numerous capacities within the ATA, including as a member of the Board of Directors, a committee chair, and a member of various committees.

Throughout his career, Dr. Ridgway has excelled in his role as a mentor and has influenced many individuals in the field that have gone on to assume leadership positions. Many fellows and trainees have benefited from the opportunity to work directly with Dr. Ridgway over the years, and he has also worked closely with the clinical fellows that attend the annual University of Colorado Endocrine Fellows Conference which he has organized and chaired for 18 years, held just before the ATA Annual Meeting. He has encouraged many endocrine fellows to participate in this annual event and to become active ATA members. He has also shared his expertise and passion for the field of thyroidology with many young physicians and research assistants, inspiring them to pursue careers in endocrinology.

 

About the ATA Annual Meeting
The 81st Annual Meeting of the American Thyroid Association will be held October 26-30, 2011 at the Renaissance Esmeralda Resort & Spa in Indian Wells (near Palm Springs), California. This four day creative and innovative scientific program, chaired by Drs. Anthony Hollenberg and Martha Zeiger, has carefully balanced clinical and basic science sessions on the latest advances in thyroidology. The ATA meeting is designed to offer continuing education for endocrinologists, internists, surgeons, basic scientists, nuclear medicine scientists, pathologists, endocrine fellows and nurses, physician assistants and other health care professionals. Visit www.thyroid.org for more information.

About the ATA
The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis and treatment of thyroid disorders and thyroid cancer. ATA is an international individual membership organization with over 1,400 members from 43 countries around the world. Celebrating its 88th anniversary, ATA delivers its mission through several key endeavors: the publication of highly regarded monthly journals, THYROID, Clinical Thyroidology and Clinical Thyroidology for Patients; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators, support of online professional, public and patient educational programs; and the development of guidelines for clinical management of thyroid disease. Visit www.thyroid.org for more information.

Media Contact
Bobbi Smith
Executive Director
American Thyroid Association
Email: bsmith@thyroid.org
Phone: 703-772-2462

# # #